Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?
Fabry disease (FD) is an X-linked, lysosomal glycosphingolipid storage disorder that occurs very rarely. Cardiac involvement may comprise of left ventricular hypertrophy (LVH), arrhythmias, conduction abnormalities, heart failure and valvular abnormalities. The goal of this study was to conduct gene...
Main Authors: | Aladağ N, Ali Barman H, Şipal A, Akbulut T, Özdemir M, Ceylaner S |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-07-01
|
Series: | Balkan Journal of Medical Genetics |
Subjects: | |
Online Access: | https://doi.org/10.2478/bjmg-2023-0010 |
Similar Items
-
<i>GLA</i> Mutations Suppress Autophagy and Stimulate Lysosome Generation in Fabry Disease
by: Ping Li, et al.
Published: (2024-03-01) -
Clinical and genetic spectrum in Chinese families with Fabry disease: a single‐centre case series
by: Xin Chen, et al.
Published: (2021-12-01) -
GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
by: Ândrea Virgínia Chaves-Markman, et al. -
Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study
by: Zongwei Lin, et al.
Published: (2024-12-01) -
Fabry disease caused by the GLA p.Gly183Asp (p.G183D) variant: Clinical profile of a serious phenotype
by: Zhiquan Liu, et al.
Published: (2024-09-01)